TABLE 2

Plasma pharmacokinetic parameters of MK-0524 and radioactivity following administration of a single p.o. dose of 40 mg of[14C]MK-0524 to healthy adult male subjects

Six healthy volunteers received 40 mg/202.4 μCi [14C]MK-0524 in two drug-filled capsules. Radioactivity in plasma was determined by liquid scintillation counting. Concentrations of MK-0524 were determined by an LC/MS/MS assay.


Subject No.

MK-0524

Radioactivity

MK-0524/Radioactivity
AUC0-∞
Cmax
Tmax
AUC0-∞
Cmax
Tmax
AUC0-∞ Ratio
Cmax Ratio
μM · h μM h μM Eq · h μM Eq h
001 10.8 1.76 1.5 31.6 3.60 1.5 0.34 0.49
002 12.6 3.59 1.0 34.2 6.05 1.0 0.37 0.59
003 10.3 1.98 1.0 33.5 4.67 1.5 0.31 0.42
004 4.32 1.27 1.5 29.5 5.17 1.5 0.15 0.25
005 12.9 2.71 1.0 48.5 6.44 1.0 0.27 0.42
006 13.6 2.73 1.0 33.3 4.50 1.5 0.41 0.61
AM 10.8 2.34 1.2 35.1 5.07 1.3
S.D.
3.40
0.83
0.3
6.80
1.05
0.3


  • AM, arithmetic mean.